Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Wooten

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Brain Structure & Function|March 11, 2018
Correction to: Investigation of brain structure in the 1-month infantDouglas C Dean, E M Planalp, W Wooten, et al.
Neuroimage|March 30, 2013
5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primateDustin W Wooten, Ansel T Hillmer, Jeffrey M Moirano, et al.
Journal of Neurochemistry|March 19, 2008
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegenerationJ Ramesh Babu, M Lamar Seibenhener, Junmin Peng, et al.
Synapse (New York, N.Y.)|June 16, 2011
Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkeyA T Hillmer, D W Wooten, J M Moirano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Pharmacokinetic Evaluation of the Tau PET Radiotracer <sup>18</sup>F-T807 (<sup>18</sup>F-AV-1451) in Human SubjectsDustin W Wooten, Nicolas J Guehl, Eline E Verwer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefwayDustin W Wooten, Ansel T Hillmer, Dhanabalan Murali, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2019
Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [<sup>18</sup>F]MK6240 in human subjectsNicolas J Guehl, Dustin W Wooten, Daniel L Yokell, et al.
Translational Oncology|September 1, 2023
Evaluation of a semi-automated approach for FDG PET image analysis for routine clinical application in patients with multiple myelomaTyler J Wellman, Sarah R Mudd, Kelly N Godby, et al.
American Journal of Preventive Medicine|March 1, 1996
A multisite field test of the acceptability of physical activity counseling in primary care: project PACEB J Long, K J Calfas, W Wooten, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
Correction to: Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [<sup>18</sup>F]MK6240 in human subjectsNicolas J Guehl, Dustin W Wooten, Daniel L Yokell, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Brain Structure & Function|March 11, 2018
Correction to: Investigation of brain structure in the 1-month infantDouglas C Dean, E M Planalp, W Wooten, et al.
Neuroimage|March 30, 2013
5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primateDustin W Wooten, Ansel T Hillmer, Jeffrey M Moirano, et al.
Journal of Neurochemistry|March 19, 2008
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegenerationJ Ramesh Babu, M Lamar Seibenhener, Junmin Peng, et al.
Synapse (New York, N.Y.)|June 16, 2011
Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkeyA T Hillmer, D W Wooten, J M Moirano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Pharmacokinetic Evaluation of the Tau PET Radiotracer <sup>18</sup>F-T807 (<sup>18</sup>F-AV-1451) in Human SubjectsDustin W Wooten, Nicolas J Guehl, Eline E Verwer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefwayDustin W Wooten, Ansel T Hillmer, Dhanabalan Murali, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2019
Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [<sup>18</sup>F]MK6240 in human subjectsNicolas J Guehl, Dustin W Wooten, Daniel L Yokell, et al.
Translational Oncology|September 1, 2023
Evaluation of a semi-automated approach for FDG PET image analysis for routine clinical application in patients with multiple myelomaTyler J Wellman, Sarah R Mudd, Kelly N Godby, et al.
American Journal of Preventive Medicine|March 1, 1996
A multisite field test of the acceptability of physical activity counseling in primary care: project PACEB J Long, K J Calfas, W Wooten, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
Correction to: Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [<sup>18</sup>F]MK6240 in human subjectsNicolas J Guehl, Dustin W Wooten, Daniel L Yokell, et al.
Pageof 17